Single-dose drug levels, disease biomarkers and initial safety and immune-response data are on the presentation agenda; the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results